Impact of baseline abnormal liver enzymes in the outcome of COVID-19 infection.

Farias, João Pedro; Codes, Liana; Vinhaes, Diana; Amorim, Ana Paula; D'Oliveira, Ricardo Cruz; Farias, Alberto Queiroz; Bittencourt, Paulo Lisboa

Farias, João Pedro; Codes, Liana; Vinhaes, Diana; Amorim, Ana Paula; D'Oliveira, Ricardo Cruz; Farias, Alberto Queiroz; Bittencourt, Paulo Lisboa.

Afiliação

Farias JP; University of Salvador-Unifacs, Salvador, Bahia, Brazil.
Codes L; Portuguese Hospital of Bahia, Salvador, Bahia, Brazil.
Vinhaes D; Bahiana School of Medicine and Public Health, Salvador, Bahia, Brazil.
Amorim AP; Portuguese Hospital of Bahia, Salvador, Bahia, Brazil.
D'Oliveira RC; Portuguese Hospital of Bahia, Salvador, Bahia, Brazil.
Farias AQ; Portuguese Hospital of Bahia, Salvador, Bahia, Brazil.
Bittencourt PL; Bahiana School of Medicine and Public Health, Salvador, Bahia, Brazil.

Transl Gastroenterol Hepatol ; 8: 5, 2023.

Article em En | MEDLINE | ID: mdl-36704646

Palavras-chave

COVID-19; Liver enzymes; mortality

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Transl Gastroenterol Hepatol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Brasil

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google